You searched for "therapeutics"

398 results found

Andrew Geddes Becomes Vice President and Head of European Operations at Glaukos

Glaukos announces that Andrew Geddes is to become Vice President and Head of European Operations, recognising his eight years of leadership and contributions to the company’s growth. In this role, Geddes will lead Glaukos’ strategic expansion in Europe, Middle East...

Reclassifying genetic variants in inherited retinal diseases

The authors present a retrospective study of 142 gene sequence variants from 28 patients with vitreoretinal dystrophies which were re-interpreted based on American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) guidelines. Overall, there was...

CRATER 2025

The Conference on Recent Advances in Translational Eye Research 2025

International Ophthalmology Conference 4th Edition

A transformative experience awaits at the “4th Edition of International Ophthalmology Conference” (IOC 2026), taking place from March 23-25, 2026, in Singapore and Virtually. Anchored in the theme "Unlocking New Frontiers in Vision Science and Eye Care", this global platform...

Moorfields: Medical retina pathways consent course

This brand new, unique MR Pathways consent course is specially designed for nurses, optometrists, doctors and others healthcare professional groups working in medical retina subspeciality in ophthalmology. The MR Pathway consent course enables the multi professional groups to embed the...

Moorfields medical retina consent pathways course

This brand new, unique MR Pathways consent course is specially designed for nurses, optometrists, doctors and others healthcare professional groups working in medical retina subspeciality in ophthalmology. The MR Pathway consent course enables the multi professional groups to embed the...

Seeing mitochondrial disease

This review highlights mitochondrial diseases as the most common inherited neurometabolic disorders, often affecting multiple high-energy organs, with eye involvement frequently representing the earliest or predominant feature. Diagnosis is challenging due to significant genetic and clinical heterogeneity, including variable expressivity,...

What's trending Apr/May 2022

A round-up of the eye-related hot topics that have been trending over the last few weeks. #ArgusI #ArgusII #bioniceye #retinitispigmentosa #SecondSight Remember Argus I & Argus II? Its star burned bright, touted as the future of treatment for retinitis pigmentosa....

Development of retinoblastoma care in Indonesia and the role of multidisciplinary team meetings

In the second article of a two-part series (See Part 1 here), the authors focus on the diagnosis and management of retinoblastoma in Indonesia. COVID-19 doesn’t get thanked for many things, but on 19 December 2020 as the world grew...

Addressing childhood blindness in sub-Saharan Africa

In this article, the authors explore paediatric ophthalmology subspecialist fellowship training in African nations south of the Sahara. Until recently, most African ophthalmologists who wished to pursue a subspecialty ophthalmology training fellowship had to go abroad. There is a huge...

Maximising the ocular surface prior to cataract surgery: The old and the new modalities of treatment

Cataract surgery is among the most commonly performed surgical procedures worldwide. Over time, it has evolved from a lens-extraction procedure into a refractive intervention that demands meticulous perioperative planning and precision to achieve optimal outcomes. Optimisation of the ocular surface...

The Worshipful Company of Spectacle Makers rewards early career research

The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of its annual bronze medal award competitions for vision research. Both the winning submissions demonstrated models for earlier diagnosis of significant eye disease and have the capacity to...